Troponin-only Manchester Acute Coronary Syndromes (T-MACS) Decision Aid
ورودیهای بالینی بیمار
حداقل ۰ — حداکثر ۱۰۰۰۰ • واحد: ng/L
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Very Low Risk0–0.02
- Low Risk0.02–0.05
- Moderate Risk0.05–0.95
- High Risk0.95–1
The Troponin-only Manchester Acute Coronary Syndromes (T-MACS) Decision Aid calculates stratifying cardiovascular risk, predicting thromboembolic events, or guiding therapeutic interventions. Key inputs include hs ctnt ng l. Scores guide initiating guideline-directed medical therapy, antithrombotic or anticoagulant regimens, or urgent coronary angiography. Routine clinical application promotes standardized evidence-based patient management.
Clinical Guidelines & Evidence
Rules out acute coronary syndrome using high-sensitivity cardiac troponin T and clinical factors. Provides risk stratification for patients presenting with chest pain to the emergency department.
Clinical Indication
The Troponin-only Manchester Acute Coronary Syndromes (T-MACS) Decision Aid is indicated for bedside clinical practice to support Rules out acute coronary syndrome using high-sensitivity cardiac troponin T and clinical factors. Provides risk stratification for patients presenting with chest pain to the emergency department.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Adult patients presenting with suspected or established coronary artery disease, cardiac arrhythmias, congestive heart failure, or valvular heart defects. Clinical application is indicated across Emergency department, cardiac care unit (CCU), cardiac catheterization laboratory, and outpatient cardiology clinics.
Limitations & Contraindications
In hemodynamically unstable cardiogenic shock, cardiac arrest, or refractory acute coronary syndromes, immediate resuscitation and coronary angiography supersede scoring. Clinical exclusion: Not applicable to patients with STEMI or obvious ACS on presentation.
Clinical Pearls & Action Plan
Continuous 12-lead ECG monitoring, serial cardiac troponin measurements, and echocardiographic evaluation align with ESC/ACC/AHA clinical practice guidelines. Guideline pearl: Uses only high-sensitivity cardiac troponin T (hs-cTnT) as biomarker, not serial measurements.
Probabilistic model using logistic regression incorporating high-sensitivity cardiac troponin T concentration and clinical risk factors
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| hs_ctnt_ng_l | float | Yes | High-sensitivity cardiac troponin T concentration on arrival(ng/L) |
| ekg_ischemia | string | Yes | Presence of ischemic changes on EKG |
| crescendo_angina | string | Yes | Worsening or crescendo angina pattern |
| pain_right_arm | string | Yes | Pain radiating to right arm or shoulder |
| vomiting | string | Yes | Pain associated with vomiting |
| sweating | string | Yes | Sweating observed |
| hypotension | string | Yes | Hypotension (systolic BP <100 mmHg) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–0.02 | Very Low Risk | ACS ruled out |
| 0.02–0.05 | Low Risk | Low risk |
| 0.05–0.95 | Moderate Risk | Intermediate risk |
| 0.95–1 | High Risk | ACS ruled in |
Evidence-Based References (EBM)
- Body R, Carlton E, Sperrin M, et al. Troponin-only Manchester Acute Coronary Syndromes (T-MACS) decision aid: single biomarker re-derivation and external validation in three cohorts. Emerg Med J. 2017;34(6):349-356.
- Greenslade JH, Carlton EW, Van Hise C, et al. Diagnostic accuracy of the Troponin-only Manchester Acute Coronary Syndromes (T-MACS) decision aid with a point-of-care cardiac troponin assay. Acad Emerg Med. 2020;27(6):459-466.